Luen Bik To

Luen Bik To

UNVERIFIED PROFILE

Are you Luen Bik To?   Register this Author

Register author
Luen Bik To

Luen Bik To

Publications by authors named "Luen Bik To"

Are you Luen Bik To?   Register this Author

15Publications

431Reads

14Profile Views

Comprehensive geriatric assessment predicts azacitidine treatment duration and survival in older patients with myelodysplastic syndromes.

J Geriatr Oncol 2019 Apr 22. Epub 2019 Apr 22.

School of Medicine, University of Adelaide, Adelaide, Australia; Haematology Department, Royal Adelaide Hospital, Adelaide, Australia; Cancer Research, Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2019.02.002DOI Listing
April 2019

Screening for deficits using the G8 and VES-13 in older patients with Myelodysplastic syndromes.

J Geriatr Oncol 2019 Apr 30. Epub 2019 Apr 30.

School of Medicine, University of Adelaide, Adelaide, Australia; Haematology Department, Royal Adelaide Hospital, Adelaide, Australia; Cancer Research, Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2019.04.012DOI Listing
April 2019

The Prospective Evaluation of the Net Effect of Red Blood Cell Transfusions in Routine Provision of Palliative Care.

J Palliat Med 2017 10 9;20(10):1152-1157. Epub 2017 Jun 9.

1 Palliative and Supportive Services, Flinders University , Adelaide, Australia .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jpm.2017.0072DOI Listing
October 2017

Predicting Perioperative Transfusion in Elective Hip and Knee Arthroplasty: A Validated Predictive Model.

Anesthesiology 2017 08;127(2):317-325

From the Division of Aged Care, Rehabilitation and Palliative Care, Modbury Hospital, Modbury, South Australia, Australia (J.T.); School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, Australia (J.T.); Blood, Organ and Tissue Programs, Public Health and Clinical Systems, Department of Health, Adelaide, South Australia, Australia (R.S.); Faculty of Health Sciences (R.S.) and Flinders Centre for Epidemiology and Biostatistics, School of Medicine (S.W.K.), Flinders University, Bedford Park, South Australia, Australia; South Australia Bloodsafe Program, Adelaide, Australia (K.R.); Queen Elizabeth Hospital, Woodville, South Australia, Australia (K.R.); Departments of Haematology (B.K.) and Orthopaedics and Trauma (D.H.), Clinical Haematology Service (L.B.T.), and Clinical Section (L.B.T.), Royal Adelaide Hospital, Adelaide, South Australia, Australia; and Discipline of Orthopaedics and Trauma (D.H.) and Clinical Pathology (L.B.T.), University of Adelaide, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/ALN.0000000000001709DOI Listing
August 2017

Can We Detect Transfusion Benefits in Palliative Care Patients?

J Palliat Med 2016 Oct 29;19(10):1110-1113. Epub 2016 Jun 29.

2 Discipline, Palliative and Supportive Services, Flinders University , Adelaide, South Australia, Australia .

View Article

Download full-text PDF

Source
http://www.liebertpub.com/doi/10.1089/jpm.2016.0073
Publisher Site
http://dx.doi.org/10.1089/jpm.2016.0073DOI Listing
October 2016

Outcomes of lymphoma in South Australia, 1977-2007.

Med J Aust 2012 Jan;196(1):54-7

Haematology Directorate, SA Pathology and Haematology Unit, Royal Adelaide Hospital, Adelaide, SA. Brendon.Kearney@ health.sa.gov.au

View Article

Download full-text PDF

Source
https://www.mja.com.au/system/files/issues/196_01_160112/kea
Web Search
http://dx.doi.org/10.5694/mja11.10002DOI Listing
January 2012

Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells.

Haematologica 2010 May 16;95(5):776-84. Epub 2009 Dec 16.

Myeloma Research Program, Division of Haematology, Centre for Cancer Biology-SA Pathology and University of Adelaide, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2009.015628DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864384PMC
May 2010

The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro.

Bone 2004 Jan;34(1):112-23

Myeloma and Mesenchymal Research Group, Matthew Roberts Foundation Laboratory, Division of Haematology, Institute of Medical and Veterinary Science, Adelaide 5000, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bone.2003.08.013DOI Listing
January 2004

The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE).

J Bone Miner Res 2004 Jan;19(1):147-54

Myeloma and Mesenchymal Research Group, Matthew Robert Foundation Laboratory, Division of Haematology, Institute of Medical and Veterinary Science, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1359/jbmr.2004.19.1.147DOI Listing
January 2004